Harch HBOT

What Harch HBOT does

Harch HBOT (legal name: Harch Hyperbarics, Inc.) is a founder-led private medical practice founded in 1986 by Dr. Paul G. Harch, M.D. and based in Marrero/Metairie, Louisiana. The practice delivers Hyperbaric Oxygen Therapy (HBOT) using hardshell monoplace clear acrylic chambers and individualized dosing protocols, treating more than 100 conditions with a primary focus on neurological indications — including pediatric cerebral palsy, autism, drowning and anoxic brain injury, veteran traumatic brain injury (TBI) and PTSD, stroke, multiple sclerosis, dementia, and migraine. Differentiated technology includes a patent-pending qEEG-based individualized dosing method that measures how an individual brain responds to different pressure and oxygen levels, a precision dosing protocol tailored to patient, condition, and time since onset, and SPECT brain blood flow imaging used both as a diagnostic service and to objectively track treatment response.

The business operates a sales-led, physician-referral and direct-patient model. Revenue is generated from cash-pay hyperbaric oxygen therapy treatment sessions delivered in-clinic, augmented by two in-home extensions — a Long-Term In-Home HBOT program (chamber installation and family training) and an In-Home Concierge HBOT service (technician-delivered treatment) — for patients who have demonstrated responsiveness but cannot travel. Pricing is quote-based and not publicly disclosed; historical Medicare reimbursement figures cited in media were approximately $8,000 for 40 sessions and $16,000 for an 80-session regimen, indicating high ticket size per case. Customers are predominantly individual patients (with some international travel to the clinic), and acquisition is driven by educational content marketing, patient testimonials and case studies, media and PR coverage, documentary filmmaking partnerships, and Dr. Harch's reputation, published research, and Congressional presentations. The practice is associated with a separately established non-profit research entity, the Hyperbaric Institute, directed by Dr. Harch.

Name

Harch HBOT

Legal name

Harch Hyperbarics, Inc.

Website

https://hbot.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1–10 employees

Short description

Harch HBOT is a founder-led private medical practice founded in 1986 that delivers individualized Hyperbaric Oxygen Therapy to patients with neurological and related conditions, including pediatric brain injuries, veteran TBI/PTSD, stroke, and dementia, using precision dosing, qEEG-based protocols, and SPECT imaging.

Ownership category

akta.pro rank

Product category

Hyperbaric Medicine Services

NAICS

Other Individual and Family Services (624190)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

akta.pro secondary industries

Home Health Aide (HHA) Services (Medically Directed) (HSABACAB), Home & Community-Based Services (HCBS) Coordination & Case Management (HSABAIAM)

Keywords

• Hyperbaric oxygen therapy
• Neurological condition treatment
• Traumatic brain injury therapy
• In-home hyperbaric services
• Personalized medical dosing

Headquarters

HQ city

Marrero

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Hyperbaric Oxygen Therapy Treatment Sessions: Direct patient payments for HBOT treatment sessions delivered in clinic or at home. Treatment courses typically involve multiple sessions. In-home chamber installation and training services provided as add-on.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Harch HBOT is a specialized hyperbaric medicine practice providing precision-dosed Hyperbaric Oxygen Therapy (HBOT) in monoplace hardshell chambers for over 100 different medical conditions, with a primary focus on neurological conditions including traumatic brain injury, PTSD, stroke, dementia, cerebral palsy, autism, and drowning-related anoxic brain injury. Treatment is individualized to each patient, condition, and stage of disease using a patent-pending qEEG-based dosing protocol and SPECT brain imaging for objective progress tracking. Services are delivered in-clinic in Metairie, Louisiana, and through in-home long-term and concierge HBOT programs.

Product overview

Harch HBOT operates as a specialized hyperbaric medicine practice offering Hyperbaric Oxygen Therapy (HBOT) as its core treatment service. The company differentiates itself through individualized dosing protocols and advanced diagnostic capabilities. Key offerings include: (1) Hyperbaric Oxygen Therapy using hardshell chambers with full pressure/oxygen range, (2) qEEG-Based Individualized Dosing (patent pending) for personalized treatment protocols, (3) In-Home Long-Term HBOT for ongoing treatment, (4) In-Home Concierge HBOT with technician services, and (5) SPECT Brain Imaging for treatment assessment. The practice, led by Dr. Paul Harch, has operated since 1986 and treats over 100 different conditions, primarily focused on neurological conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Hyperbaric Oxygen Therapy (HBOT) Primary medical treatment service using pressurized oxygen chambers to enhance healing by delivering increased oxygen to tissues throughout the body. Harch HBOT offers precision-dosing customized to each patient, condition, and time of intervention using hardshell chambers with the full range of pressures and oxygen content. Indicated for over 100 conditions including TBI, PTSD, stroke, cerebral palsy, autism, drowning-related anoxic brain injury, and birth injuries.
• qEEG-Based Individualized HBOT Dosing A patent-pending approach using quantitative electroencephalogram (qEEG) technology to identify how an individual brain responds to different pressure and oxygen levels, enabling personalized HBOT dosing protocols for neurological conditions.
• Long-Term In-Home HBOT Program
• In-Home Concierge HBOT Service
• SPECT Brain Blood Flow Imaging

Quantifiable outcome

• Approximately 80% of autistic patients will see improvement with HBOT
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/harch-hbot

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Harch HBOT